ANTX
AN2 Therapeutics, Inc.
$4.42
-0.28 (-5.96%)
At close · Jul 2
Market Cap
$159.19M
Shares
36,016,161
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-08-15 | RA Capital Healthcare Fund LP | Affiliate | 1,699,998 | 2024-08-15 | BTIG, LLC |
| 2024-08-15 | RA Capital Nexus Fund II, L.P. | Affiliate | 299,999 | 2024-08-15 | BTIG, LLC |
| 2024-01-18 | Z3 TRUST | Director | 100,000 | 2024-01-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-16 | Adjuvant Global Health Technology Fund DE, L.P. | Shareholder | 15,907 | 2024-01-16 | Merrill |
| 2024-01-16 | Adjuvant Global Health Technology Fund, L.P. | Shareholder | 84,093 | 2024-01-16 | Merrill |
| 2024-01-10 | MGC VENTURE PARTNERS QP 2018 ,LP | Officer | 11,033 | 2024-01-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-10 | MGC VENTURE PARTNERS 2018 ,LP | Officer | 9,443 | 2024-01-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-02 | ERIC EASOM | Officer | 2,777 | 2024-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-01-02 | KEVIN KRAUSE | Officer | 10,000 | 2024-01-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-11-14 | ADJUVANT CAPITAL GP, L.P. | Officer | 1,810 | 2023-11-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-10-02 | ADJUVANT CAPITAL GP, L.P. | Officer | 5,672 | 2023-10-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-09-29 | ADJUVANT CAPITAL GP, L.P. | Officer | 86,398 | 2023-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-23 | ADJUVANT CAPITAL GP, L.P. | Officer | 30,000 | 2023-08-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–13 of 13 filings